SO-27 Efficacy and response rates of the RENCA Macrobead therapy (RMB): A novel approach to the treatment of metastatic colorectal cancer. phase II clinical trials [U.S. FDA BB-IND 10091]
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI